Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • Medical Jobs
  • Medical Matrimony
  • MD Brand Connect
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Diabetes and Endocrinology
  • Diabetes and Endocrinology Guidelines
  • Earlier initiation of...

Earlier initiation of GLP-1 RAs Linked to Better Glycemic Control in Adolescents with T2D

Dr. Shravani DaliWritten by Dr. Shravani Dali Published On 2022-06-03T20:00:37+05:30  |  Updated On 2022-06-03T20:00:46+05:30
Earlier initiation of GLP-1 RAs Linked to Better Glycemic Control in Adolescents with T2D

Earlier initiation of GLP-1 Receptor agonists (with in one year of diagnosis of diabetes) is linked to better glycemic control in adolescents with type 2 diabetes mellitus, according to a recent study published in the Diabetes, Obesity, and Metabolism. Type 2 diabetes (T2D) in youth is a more aggressive disease that is associated with earlier co-morbidities compared with T2D in...

Earlier initiation of GLP-1 Receptor agonists (with in one year of diagnosis of diabetes) is linked to better glycemic control in adolescents with type 2 diabetes mellitus, according to a recent study published in the Diabetes, Obesity, and Metabolism.

Type 2 diabetes (T2D) in youth is a more aggressive disease that is associated with earlier co-morbidities compared with T2D in adulthood. Treatment guidelines for paediatric T2D first recommend lifestyle management and metformin, which rarely achieve meaningful body mass index (BMI) reduction.

The electronic health record (EHR) of a large medical centre was queried for all patients, aged 10-20 years, billed for T2D from January 2018 to August 2020 with a diagnosis of T2D after 2015. Patients were included if they had been diagnosed with T2D by a HbA1c measurement of 6.5% or higher and did not have diabetes autoantibodies. Each participant's EHR was reviewed from date of diagnosis to August 2021 to ensure that all patients had T2D, and all data at least 1 year postdiagnosis were included. This study was approved by the institution's Institutional Review Board.

The results are:

The most frequently prescribed GLP-1RA was liraglutide (n = 32; 59.3% of prescriptions); 46.9% (n = 15) prescriptions were written prior to FDA approval of liraglutide for youth with T2D. Semaglutide subcutaneous was prescribed for 13 patients (24.1%), followed by exenatide ER (n = 4; 7.4%), exenatide twice-daily (n = 2; 3.7%), deglutide (n = 2; 3.7%), and semaglutide oral (n = 1; 1.8%). The majority of GLP-1RA prescriptions (n = 35; 64.8%) were prescribed 'off-label'; either for patients prescribed liraglutide or exenatide ER prior to approval or another GLP-1RA prescribed for patients younger than 18 years. Among all patients prescribed GLP-1RAs, 66.7% (n = 36) were also prescribed long-acting insulin with a mean dose of 0.42 ± 0.32 units/kg/d. Sixteen patients (29.6%) prescribed GLP-1RAs were prescribed metformin without insulin, and 64.4% (n = 29) were prescribed both metformin and insulin.

Thus, this retrospective chart review described GLP-1RA prescribing patterns for adolescents with T2D and predominantly severe obesity (BMI > 1.2 × 95th percentile). Interestingly, patients who were prescribed a GLP-1RA within 1 year of T2D diagnosis were more probable to be in better glycaemic control and less probable to also be prescribed insulin than those who were prescribed a GLP-1RA after 1 year since their diagnosis.

Reference:

Glucagon-like peptide-1 receptor agonist prescribing patterns in adolescents with type 2 diabetes by Megan O. Bensignor et al. published in the Diabetes, Obesity, and Metabolism.

https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.14681


Earlier Use GLP-1 RAs Linked Better Glycemic intensive glycemic control Adolescents type2 diabetes Diabetes Obesity and Metabolism 
Source : Diabetes, Obesity, and Metabolism
Dr. Shravani Dali
Dr. Shravani Dali

    BDS

    Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.

    Show Full Article
    Next Story
    Similar Posts
    NO DATA FOUND

    Editorial

    Journal Club Today

    Health News Today

    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok